Rus En Es
Main / Company's news / GEROPHARM Expertise in the Development of Biotechnological Products is Recognised Internationally

GEROPHARM Expertise in the Development of Biotechnological Products is Recognised Internationally

9 July 2019

GEROPHARM expertise in the development of biotechnological products is recognised internationally.

Experts of the company’s R&D centre conducted a two-day seminar for representatives of the Ministry of Health of Nicaragua. The event was also attended by specialists of the Saint Petersburg Research Institute for Vaccines and Serums with the Russian Federal Medical-Biological Agency and the Mechnikov Institute of Biotechnology.

The company specialists explained what insulin analogues are and what market potential they have, analysed the biosimilars regulatory status worldwide and requirements to the development programmes thereof. In addition, practical issues of physical-chemical, non-clinical and clinical comparability and interchangeability studies of biosimilar medicinal products were discussed. The specifics of pharmacovigilance in this product category were discussed in detail.

The guests were given a tour of the GEROPHARM manufacturing site in Pushkin.

You are a health care professional?

Go up